FDA.reportPublic FDA data

LISINOPRIL

Product NDC
31722-417
11-digit product format
317220417
Labeler code
31722
Product ID
31722-417_059f5795-5de9-4a69-bced-580cf6272799
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LISINOPRIL
Dosage form
TABLET
Route
ORAL
Labeler
Camber Pharmaceuticals Inc.
Application
ANDA203508
Marketing category
ANDA
Marketing start
2013-11-15
Marketing end
0000-00-00
Substance
LISINOPRIL
Active strength
3 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
31722-417-012025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-052025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-102025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-302025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-012020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-052020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-102020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-417-302020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-417-01EA - Each31722-41787ed5853-9318-4a5e-b5ba-7941d1e7ae6f12014-02-04
31722-417-10EA - Each31722-417df283136-633f-41c7-837e-c22e5a06b62f12014-02-04